Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study.

MLA

Bernier-Chastagner, Valerie, et al. “Topotecan as a Radiosensitizer in the Treatment of Children with Malignant Diffuse Brainstem Gliomas: Results of a French Society of Paediatric Oncology Phase II Study.” Cancer, vol. 104, no. 12, Dec. 2005, pp. 2792–97. EBSCOhost, https://doi.org/10.1002/cncr.21534.

APA

Bernier-Chastagner, V., Grill, J., Doz, F., Bracard, S., Gentet, J. C., Marie-Cardine, A., Luporsi, E., Margueritte, G., Lejars, O., Laithier, V., Mechinaud, F., Millot, F., Kalifa, C., & Chastagner, P. (2005). Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer, 104(12), 2792–2797. https://doi.org/10.1002/cncr.21534

Chicago

Bernier-Chastagner, Valerie, Jacques Grill, Francois Doz, Serge Bracard, Jean Claude Gentet, A Marie-Cardine, E Luporsi, et al. 2005. “Topotecan as a Radiosensitizer in the Treatment of Children with Malignant Diffuse Brainstem Gliomas: Results of a French Society of Paediatric Oncology Phase II Study.” Cancer 104 (12): 2792–97. doi:10.1002/cncr.21534.